Part,  Chapter, Paragraph

1   II,     5.  2.  4|     cholesterol: prevalence of hypercholesterolemia is difficult to describe
2   II,     5.  2.  4|       mmol/l and prevalence of hypercholesterolemia in 27 EU countries for men
3   II,     5.  2.  4|   definition (hypertension and hypercholesterolemia) and age ranges, it was
4   II,     5.  2.  5|       such as hypertension and hypercholesterolemia) must be treated with increasing
5   II,     9        | important risk factor) than to hypercholesterolemia, HMG-CoA reductase inhibitors (
6   II,     9.  3.  1| important risk factor) than to hypercholesterolemia, HMG-CoA reductase inhibitors (
7   IV,    12.  2    |       such as hypertension and hypercholesterolemia) must be treated with increasing